240 related articles for article (PubMed ID: 12239312)
21. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
[TBL] [Abstract][Full Text] [Related]
22. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
Ho SH; Martin F; Higginbottom A; Partridge LJ; Parthasarathy V; Moseley GW; Lopez P; Cheng-Mayer C; Monk PN
J Virol; 2006 Jul; 80(13):6487-96. PubMed ID: 16775336
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.
Argyris EG; Acheampong E; Nunnari G; Mukhtar M; Williams KJ; Pomerantz RJ
J Virol; 2003 Nov; 77(22):12140-51. PubMed ID: 14581551
[TBL] [Abstract][Full Text] [Related]
24. Role for influenza virus envelope cholesterol in virus entry and infection.
Sun X; Whittaker GR
J Virol; 2003 Dec; 77(23):12543-51. PubMed ID: 14610177
[TBL] [Abstract][Full Text] [Related]
25. The endocytic pathway for human immunodeficiency virus infection.
Pauza CD
Adv Exp Med Biol; 1991; 300():111-38; discussion 139-44. PubMed ID: 1781341
[TBL] [Abstract][Full Text] [Related]
26. A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.
Vidricaire G; Tremblay MJ
J Mol Biol; 2007 May; 368(5):1267-83. PubMed ID: 17395200
[TBL] [Abstract][Full Text] [Related]
27. Fenretinide inhibits HIV infection by promoting viral endocytosis.
Finnegan CM; Blumenthal R
Antiviral Res; 2006 Feb; 69(2):116-23. PubMed ID: 16375981
[TBL] [Abstract][Full Text] [Related]
28. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
[TBL] [Abstract][Full Text] [Related]
29. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
30. Depletion and exchange of cholesterol from the membrane of vesicular stomatitis virus by interaction with serum lipoproteins or poly(vinylpyrrolidone) complexed with bovine serum albumin.
Pal R; Barenholz Y; Wagner RR
Biochemistry; 1981 Feb; 20(3):530-9. PubMed ID: 6260133
[TBL] [Abstract][Full Text] [Related]
31. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.
Nguyen DH; Hildreth JE
J Virol; 2000 Apr; 74(7):3264-72. PubMed ID: 10708443
[TBL] [Abstract][Full Text] [Related]
32. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.
Rogalin HB; Heldwein EE
J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol dependence of HTLV-I infection.
Wielgosz MM; Rauch DA; Jones KS; Ruscetti FW; Ratner L
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):43-50. PubMed ID: 15665643
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
Bremer CM; Bung C; Kott N; Hardt M; Glebe D
Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
[TBL] [Abstract][Full Text] [Related]
37. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.
Khan M; Garcia-Barrio M; Powell MD
J Virol; 2001 Dec; 75(24):12081-7. PubMed ID: 11711598
[TBL] [Abstract][Full Text] [Related]
38. Specific incorporation of cyclophilin A into HIV-1 virions.
Franke EK; Yuan HE; Luban J
Nature; 1994 Nov; 372(6504):359-62. PubMed ID: 7969494
[TBL] [Abstract][Full Text] [Related]
39. A novel sorting strategy of trichosanthin for hijacking human immunodeficiency virus type 1.
Zhao WL; Zhang F; Feng D; Wu J; Chen S; Sui SF
Biochem Biophys Res Commun; 2009 Jul; 384(3):347-51. PubMed ID: 19409877
[TBL] [Abstract][Full Text] [Related]
40. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
